Cision PR Newswire

EFICYENT to Join Banks and Fintech Companies at Singapore FinTech Festival 2026

DUBAI, UAE, Nov. 15, 2026 /PRNewswire/ -- EFICYENT, a cross-border payment platform, is going to attend the Singapore FinTech Festival (SFF) 2026, which is going to be one...

PASCAL Unveils Its 2026 Holiday Gift Edit, Featuring Timeless Watches and Color-Driven Gifts

Launching November 14, the seasonal event centers on the Timeless Classic Collection, coordinated gifting...

AJOVY® Formally Included in China’s National Reimbursement Drug List 2026

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- On November 14, NeuroGen announced that it's in-licensed innovative...

SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug ‘SNB-101’ on Gastric Cancer.

SEONGNAM, South Korea, Dec. 24, 2025 /PRNewswire/ -- SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD)...

From Discoverative AI to the Entropy of Tolerance: Tianqiao Chen’s Vision of Human-AI Co-Evolution

SAN MATEO, Calif., Dec. 24, 2025 /PRNewswire/ -- Shanda Group has entered a period of renewed visibility, with a series of incubated ventures coming...

Xiao-I Corporation Announces Receipt of Nasdaq Listing Deficiency Notices

SHANGHAI, Dec. 24, 2025 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) (the "Company") today announced that it has received two written notifications from the Listing Qualifications...

CES 2026 Preview: Kosmera Prototype Debuts, Redefining the Intelligent Hypercar

LAS VEGAS, Dec. 24, 2025 /PRNewswire/ -- Kosmera, a brand dedicated to forging the future of intelligent mobility, announced today that its first-ever prototype—a...